Event overview

Advanced platform approaches including omics, clinical biomarker studies, and AI analytics, are enabling unprecedented insights and advances in our ability to identify novel therapeutic targets. Translating these targets into validated precision medicines requires disease-relevant in vitro biology, novel therapeutic modalities, and rigorous use of next generation technology platforms.  

In this, the first-ever ELRIG event on the island of Ireland, we will showcase remarkable science that is validating new targets, advancing novel therapeutic classes, and translating these into patient benefit. Discover the breakthroughs shaping the future direction of medicine at this pioneering one-day event designed for drug discovery and biomarker scientists across academia and industry.

Our programme combines cutting-edge talks, interactive discussions, and dedicated early-career networking opportunities to foster collaboration and spark new insights.